Legal, business and scientific experience in one package
With first-hand experience leading a biotech start-up, a biochemistry doctorate and twenty years of patent procurement experience, Thuy adeptly blends her legal and scientific knowledge to help clients advance their business goals. When drafting and prosecuting biotechnology and pharmaceutical patents, Thuy looks beyond protecting her client’s innovations to consider their impact on market position and corporate strategy.
Unrivalled expertise in biotechnology and pharmaceutical patenting
Thuy’s experience extends to all aspects of patent procurement in Canada, including preparing patentability infringement and validity opinions, developing and managing patent portfolios, conducting freedom-to-operate and due diligence evaluations, strategic planning, and general client counselling on patent matters. She’s also highly knowledgeable about the patent-related regulatory requirements applied to biopharmaceuticals being marketed in Canada.
Broad technical knowledge and client base
Thuy bolsters her patent expertise with her strong technical understanding which lies in areas of biochemistry including carbohydrates, histocytochemistry, immunochemistry, cell biology especially in intracellular trafficking and chaperone activity, immunogenetics, molecular biology, agricultural biotechnology, stem cells and personalized medicine.
Thuy counsels clients ranging from small biotechnology start-ups and universities to major biochemical, biopharmaceutical and bioagricultural companies. Earlier in her career, Thuy was a key leader in a biotechnology spin-off company in Canada.
Thuy leads our in-house educational training and seminars on biotech patent law.
- Industry Involvement
- In the Media
- “Cross-Border IP Challenges in Strategic Research Collaborations,” panel presentation at the BIO International Conference in Boston, USA, June 2012
- Fellow, Intellectual Property Institute of Canada
- Member, Legal Affairs Advisory Board of BioteCanada
- "Biopharmaceutical Companies Set to Benefit From International Trade Agreements" (co-author: Daphne Lainson), Biotechnology Focus, December 2015/January 2016, p. 28